ClinicalTrials.Veeva

Menu
V

Veracity Neuroscience, LLC. | Memphis, Tennessee

Research site
(Unclaimed)

Site insights

Top conditions

Top treatments

AMX0035
CVN424
Suvecaltamide

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

5 of 5 total trials

A Study of Suvecaltamide in Adults With Moderate to Severe Residual Tremor in Parkinson's Disease

This is a 17-week double-blind, placebo-controlled, randomized, flexible-dosing, parallel-group, multicenter study designed to evaluate the efficacy...

Enrolling
Tremor
Parkinson Disease
Drug: Suvecaltamide
Drug: Placebo

ORION Trial is a trial to evaluate the efficacy and safety of AMX0035 in participants with Progressive Supranuclear Palsy (PSP), consisting of a rand...

Enrolling
PSP
Neurodegenerative Diseases
Other: Placebo
Drug: AMX0035

This is a multicenter, 12-week, placebo-controlled clinical trial of CVN424 150 milligrams (mg) tablets in early, untreated Parkinson's Disease (PD)....

Enrolling
Parkinson's Disease
Drug: Placebo
Drug: CVN424 150 mg

This is a double-blinded, controlled, randomized clinical trial (RCT) to establish the safety and efficacy of a non-invasive neuromodulation device f...

Enrolling
Parkinson Disease
Parkinson's Disease and Parkinsonism
Device: Non-invasive brainstem stimulation

This study seeks to establish the safety and efficacy of extended twice daily treatments for treating symptoms associated with PD. Only participants...

Invitation-only
Parkinson Disease
Parkinson's Disease and Parkinsonism
Device: Open Label Extension Study

Trial sponsors

Scion NeuroStim logo
A
C
Jazz Pharmaceuticals logo

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems